Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Deliver life-changing therapies consisting of a safe and renewable beta cell source capable of restoring glucose control and achieving long-term insulin independence without the need for chronic broad immunosuppression – a functional cure.
Característiques principals
Specific Information regarding JDRF’s Beta Cell Replacement research priority area can be found at:
http://grantcenter.jdrf.org/wp-content/uploads/2019/07/Beta-Cell-Replacement-Program-Strategy.pdf
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@imim.es Ext.: 1576
Carol Barnwell: cbarnwell@imim.es Ext.1670
Convocatòria (URL)
http://grantcenter.jdrf.org/rfa/beta-cell-replacement-innovative-grants-2/
Requisits
Proposals may be submitted by domestic and foreign non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government. Innovative (but not pilot and research tool) proposals from for-profit organizations will also be considered.
Applicants must hold an MD, DMD, DVM, PhD, or equivalent and have a faculty position or equivalent at a college, university, medical school, or other research facility. There are no citizenship requirements for this program.
To assure continued excellence and diversity among applicants and awardees, JDRF welcomes proposals from all qualified individuals and encourages proposals from persons with disabilities, women, and members of minority groups underrepresented in the sciences.
Dotació
110,000 USD maximum/year for one year, including up to 10% for indirect costs.
Durada
1 year
Documentació
Proposals should be submitted electronically through the Research Management System (RMS360):
https://jdrf.smartsimple.us/
All proposal details and templates are available to researchers in RMS360.

Arxius

Arxiu
Beta-Cell-Replacement-Innovative-RFA-FY20.pdf
Beta-Cell-Replacement-Program-Strategy.pdf